Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 5.3B | 5.7B | 5.2B | 4.8B |
| Cost of revenue | 2.8B | 2.9B | 2.5B | 2.4B |
| Gross profit | 2.5B | 2.8B | 2.7B | 2.4B |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | 623M | 631M | 561M | 531M |
| Other operating expenses | — | — | — | — |
| Operating income | 1.8B | 2.0B | 2.0B | 1.8B |
| Non operating interest income | ||||
| Income | 173M | 212M | 236M | 178M |
| Expense | 166M | 166M | 154M | 126M |
| Other income expense | -30M | 17M | 176M | 159M |
| Pretax income | 1.8B | 2.1B | 2.3B | 2.0B |
| Tax provision | 248M | 442M | 574M | 477M |
| Net income | 1.5B | 1.7B | 1.7B | 1.5B |
| Basic EPS | 0.1 | 0.2 | 0.2 | 0.2 |
| Diluted EPS | 0.1 | 0.2 | 0.2 | 0.2 |
| Basic average shares | 10.2B | 10.2B | 9.8B | 9.8B |
| Diluted average shares | 10.3B | 10.4B | 9.9B | 9.9B |
| EBITDA | 2.2B | 2.5B | 2.4B | 2.1B |
| Net income from continuing op. | 1.5B | 1.7B | 1.7B | 1.5B |
| Minority interests | -5M | 9M | -60M | -42M |
| Preferred stock dividends | — | — | — | — |